Suppr超能文献

截短的、脱敏缺陷型神经激肽受体通过一种不依赖Ras的机制介导丝裂原活化蛋白激酶的持续激活、细胞生长和转化。

Truncated, desensitization-defective neurokinin receptors mediate sustained MAP kinase activation, cell growth and transformation by a Ras-independent mechanism.

作者信息

Alblas J, van Etten I, Moolenaar W H

机构信息

Division of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

出版信息

EMBO J. 1996 Jul 1;15(13):3351-60.

Abstract

We have used the neurokinin NK-2 receptor as a model to examine how receptor desensitization affects cellular responses. The liganded receptor transiently activates phospholipase C (PLC) and is rapidly phosphorylated on Ser/Thr residues in its C-terminal domain. Mutant receptors lacking this domain mediate persistent activation of PLC. We now show that, in transfected Rat-1 cells, mutant receptor mediates ligand-induced DNA synthesis, morphological transformation and growth in soft agar, whereas wild-type (wt) receptor does not. Wt receptor causes only transient MAP kinase activation. In contrast, MAP kinase activation by mutant receptor is sustained for >4 h. Neither wt nor mutant receptor couples to Ras activation. Downregulation of protein kinase C (PKC) has little effect on MAP kinase activation, DNA synthesis and transformation. Mutant receptors also promote stronger protein tyrosine phosphorylation and stress fibre formation than does wt receptor. Thus, C-terminal truncation allows the NK-2 receptor to signal sustained MAP kinase activation, cell growth and transformation by a Ras- and PKC-independent mechanism. Our results reveal the importance of the C-terminal 'desensitization domain' in suppressing the oncogenic potential of a prototypic PLC-coupled receptor.

摘要

我们已将神经激肽NK-2受体作为模型,以研究受体脱敏如何影响细胞反应。结合配体的受体短暂激活磷脂酶C(PLC),并在其C末端结构域的丝氨酸/苏氨酸残基上迅速磷酸化。缺乏该结构域的突变受体介导PLC的持续激活。我们现在表明,在转染的大鼠1细胞中,突变受体介导配体诱导的DNA合成、形态转化和软琼脂中的生长,而野生型(wt)受体则不然。wt受体仅引起短暂的丝裂原活化蛋白激酶(MAP激酶)激活。相比之下,突变受体引起的MAP激酶激活持续超过4小时。wt受体和突变受体均不与Ras激活偶联。蛋白激酶C(PKC)的下调对MAP激酶激活、DNA合成和转化几乎没有影响。与wt受体相比,突变受体还能促进更强的蛋白酪氨酸磷酸化和应力纤维形成。因此,C末端截短使NK-2受体能够通过不依赖Ras和PKC的机制发出持续的MAP激酶激活、细胞生长和转化信号。我们的结果揭示了C末端“脱敏结构域”在抑制原型PLC偶联受体致癌潜力方面的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab8d/451898/b0982f39c359/emboj00013-0146-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验